Clorox (NYSE:CLX) Beats Q2 CY2026 Sales Expectations
Clorox (NYSE:CLX) reported Q2 CY2026 sales of $1.95 billion, down 2% year on year but 2.6% above analysts’ revenue expectations. Non-GAAP EPS was $1.66, 0.9% above consensus. The article also cites trailing 12-month revenue of $6.72 billion and notes full-year EPS guidance missed estimates.
How this was made
The 30-second read
Why it matters
Traders can reassess near-term expectations using the reported Q2 revenue beat and EPS print, but should weigh the stated gross margin miss and full-year EPS guidance falling short.
Market read
A mixed earnings read-through: consensus-beating revenue and slightly above-consensus EPS, but guidance and margin issues likely cap upside.
What to watch
The article does not quantify the magnitude of the gross margin miss or the full-year EPS guidance shortfall, limiting conviction on how severe the earnings power deterioration is.
Background
Clorox is a consumer staples brand with a large revenue base and limited major retail partner concentration, per the article’s overview.
Ticker impact
Clorox reported Q2 CY2026 revenue of $1.95B, down 2% YoY, but beat consensus by 2.6%, with non-GAAP EPS $1.66 slightly above estimates.
Near-term bias is likely mixed, with upside limited by the guidance miss and gross margin weakness despite the revenue beat.
The article provides concrete quarter results (revenue, EPS) plus two offsetting negatives (gross margin missed, full-year EPS guidance fell short), which typically dampens follow-through after a beat.
Market effects
Signals continued pressure on consumer staples top-line growth, even when brands can beat consensus on revenue.
No specific regional demand or geography disclosures in the article.
No explicit global macro or international regulatory drivers cited beyond general growth commentary.
Counterpoint
The revenue beat and modest EPS outperformance could indicate demand resilience or better-than-expected pricing, making the guidance miss more about conservatism than deterioration.
Key entities
- companyClorox
Reported Q2 CY2026 results: revenue $1.95B (down 2% YoY) beat estimates by 2.6%, non-GAAP EPS $1.66 (0.9% above consensus), with gross margin miss and full-year EPS guidance shortfall.